S&P 500   4,966.64 (-0.18%)
DOW   38,527.79 (-0.09%)
QQQ   423.59 (-0.87%)
AAPL   181.31 (-0.14%)
MSFT   399.10 (-0.92%)
META   467.11 (-0.88%)
GOOGL   142.14 (+0.72%)
AMZN   168.21 (+0.68%)
TSLA   193.97 (+0.11%)
NVDA   670.52 (-3.46%)
NIO   6.05 (+1.51%)
AMD   163.37 (-1.40%)
BABA   75.68 (+3.47%)
T   16.97 (+0.35%)
F   12.13 (-0.98%)
MU   80.59 (-0.15%)
CGC   3.42 (-3.39%)
GE   148.19 (-0.29%)
DIS   107.71 (-1.58%)
AMC   4.56 (-2.15%)
PFE   27.50 (-0.33%)
PYPL   57.59 (-1.77%)
XOM   104.75 (+1.95%)
S&P 500   4,966.64 (-0.18%)
DOW   38,527.79 (-0.09%)
QQQ   423.59 (-0.87%)
AAPL   181.31 (-0.14%)
MSFT   399.10 (-0.92%)
META   467.11 (-0.88%)
GOOGL   142.14 (+0.72%)
AMZN   168.21 (+0.68%)
TSLA   193.97 (+0.11%)
NVDA   670.52 (-3.46%)
NIO   6.05 (+1.51%)
AMD   163.37 (-1.40%)
BABA   75.68 (+3.47%)
T   16.97 (+0.35%)
F   12.13 (-0.98%)
MU   80.59 (-0.15%)
CGC   3.42 (-3.39%)
GE   148.19 (-0.29%)
DIS   107.71 (-1.58%)
AMC   4.56 (-2.15%)
PFE   27.50 (-0.33%)
PYPL   57.59 (-1.77%)
XOM   104.75 (+1.95%)
S&P 500   4,966.64 (-0.18%)
DOW   38,527.79 (-0.09%)
QQQ   423.59 (-0.87%)
AAPL   181.31 (-0.14%)
MSFT   399.10 (-0.92%)
META   467.11 (-0.88%)
GOOGL   142.14 (+0.72%)
AMZN   168.21 (+0.68%)
TSLA   193.97 (+0.11%)
NVDA   670.52 (-3.46%)
NIO   6.05 (+1.51%)
AMD   163.37 (-1.40%)
BABA   75.68 (+3.47%)
T   16.97 (+0.35%)
F   12.13 (-0.98%)
MU   80.59 (-0.15%)
CGC   3.42 (-3.39%)
GE   148.19 (-0.29%)
DIS   107.71 (-1.58%)
AMC   4.56 (-2.15%)
PFE   27.50 (-0.33%)
PYPL   57.59 (-1.77%)
XOM   104.75 (+1.95%)
S&P 500   4,966.64 (-0.18%)
DOW   38,527.79 (-0.09%)
QQQ   423.59 (-0.87%)
AAPL   181.31 (-0.14%)
MSFT   399.10 (-0.92%)
META   467.11 (-0.88%)
GOOGL   142.14 (+0.72%)
AMZN   168.21 (+0.68%)
TSLA   193.97 (+0.11%)
NVDA   670.52 (-3.46%)
NIO   6.05 (+1.51%)
AMD   163.37 (-1.40%)
BABA   75.68 (+3.47%)
T   16.97 (+0.35%)
F   12.13 (-0.98%)
MU   80.59 (-0.15%)
CGC   3.42 (-3.39%)
GE   148.19 (-0.29%)
DIS   107.71 (-1.58%)
AMC   4.56 (-2.15%)
PFE   27.50 (-0.33%)
PYPL   57.59 (-1.77%)
XOM   104.75 (+1.95%)

KALA BIO (KALA) Earnings Date, Estimates & Call Transcripts

$7.04
-0.13 (-1.81%)
(As of 01:07 PM ET)

Earnings Summary

Upcoming
Earnings Date
Mar. 1Estimated
Actual EPS
(Nov. 13)
-$3.41 Missed By -$1.26
Consensus EPS
(Nov. 13)
-$2.15
Skip Charts & View Estimated and Actual Earnings Data

KALA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KALA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

KALA BIO Analyst EPS Estimates

Current Year EPS Consensus Estimate:($18.03) EPS
Next Year EPS Consensus Estimate: ($11.86) EPS

KALA Earnings Date and Information

KALA BIO last posted its earnings data on November 13th, 2023. The reported ($3.41) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.15) by $1.26. KALA BIO has generated ($22.73) earnings per share over the last year (($22.73) diluted earnings per share). Earnings for KALA BIO are expected to grow in the coming year, from ($18.03) to ($11.86) per share. KALA BIO has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 1st, 2024 based off prior year's report dates.

KALA BIO Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/1/2024
Estimated)
------- 
11/13/2023Q3 2023($2.15)($3.41)($1.26)($3.41)--
8/4/2023Q2 2023($3.19)($4.36)($1.17)($4.36)--
5/9/2023Q1 2023($5.10)($6.99)($1.89)($6.99)--
3/3/2023Q4 2022($6.56)($7.97)($1.41)($7.97)--
11/8/2022Q3 2022$10.75$19.25+$8.50$19.25$62.50 million$0.42 million
8/11/2022Q2 2022($22.00)($19.00)+$3.00($0.38)$2.57 million$2.10 million
5/16/2022Q1 2022($9.00)($11.25)($2.25)($0.45)$3.11 million$1.37 million    
3/29/2022Q4 2021($10.75)($17.00)($6.25)($0.68)$3.38 million$1.86 million    
11/15/2021Q3 2021($11.25)($10.75)+$0.50($0.43)$5.18 million$3.07 million    
8/5/2021Q2 2021($11.50)($14.25)($2.75)($0.57)$5.05 million$3.05 million    
5/5/2021Q1 2021($12.75)($12.25)+$0.50($0.49)$3.64 million$3.27 million  
2/25/2021Q4 2020($11.50)($13.75)($2.25)($0.55)$2.39 million$2.24 million  












KALA BIO Earnings - Frequently Asked Questions

When is KALA BIO's earnings date?

KALA BIO has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 1st, 2024 based off last year's report dates. Learn more on KALA's earnings history.

Did KALA BIO beat their earnings estimates last quarter?

In the previous quarter, KALA BIO (NASDAQ:KALA) missed the analysts' consensus estimate of ($2.15) by $1.26 with a reported earnings per share (EPS) of ($3.41). Learn more on analysts' earnings estimate vs. KALA's actual earnings.

How much revenue does KALA BIO generate each year?

KALA BIO (NASDAQ:KALA) has a recorded annual revenue of $3.89 million.

How much profit does KALA BIO generate each year?

KALA BIO (NASDAQ:KALA) has a recorded net income of -$44.82 million. KALA has generated -$22.73 earnings per share over the last four quarters.

What is KALA BIO's EPS forecast for next year?

KALA BIO's earnings are expected to grow from ($18.03) per share to ($11.86) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:KALA) was last updated on 2/21/2024 by MarketBeat.com Staff